Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I'm sure all city's, counties and states pipes are standard sizes. Getting awareness to the various governments is the key to getting the business.
The money in the infrastructure bill replaces lead pipes. I hope movement goes after the valves in the replacement process. Oil and gas is not the only business that needs valves. They have cloud base for monitoring that can be used in water and sewage as well. The opportunity is their if movement can capitalize on the opportunity.
Pepe their are no guarantees in anything. You can only hope for the best. You have to join the movement. $mvnt
Short volume data FINRA under orf
Daily
CGrowth Capital Executes Consulting Agreement with Stallion Energy Group to Support Petroleum Projects
Maybe the first couple drills should get a second opinion from another energy consulting group. That would give more confidence in the drill. Many people get second opinion on things. It might give a more favorable outcome or lesson the risk on any drilling.
Date|Symbol|ShortVolume|ShortExemptVolume|TotalVolume|Market
20211122|CGRA|2716619|0|4427830|O
Pepe your the oil expert. That well they drilled in the Bahamas was supposively not deep enough. Why didn't challenger drill deeper? Is that something they couldn't do when they stopped? It seems they say their is oil deeper down. Why couldn't they continue drilling?
Maybe, the partnering company will help develop the Wyoming property.
Date|Symbol|ShortVolume|ShortExemptVolume|TotalVolume|Market
20211108|CGRA|7766783|0|14965849|O
Big dump? MM's did alot of short selling the last two days.
With Wright's experience in financing their should be no problem setting up the necessities to have an oil well drilled.
Management keeps giving a buying opportunity. Once the door is closed its closed for the buying opportunity.
Don't you need to be current to dilute?
Maybe, Christmas presents? Lol
The header translated
Economic evaluation during the stages of a BH project.
By: Maria Isabel Santes Coronado
From the tweet
another order of chemical injection pump
Prior orders?
Did the price of arrayit happen to go up with the emergency use authorization as $PRPO? Just always the other stock moves.
The website is still up and running. So they must still be in business.
If mark is found guilty. What's gonna happen to his shares? What will happen to arrayit? Can the court appoint an iterim ceo till one gets elected. Can arrayit survive? What about the ovarian test?
Anything new with Taub or Iconic?
Anything new on pacer? To anyone that has a pacer account.
The arrayit website is operating
That's a good sign. Must not be a scam.
Anything new with iconic negotiations?
Maybe, Working on a vaccine
You think Mark would make a portable device that can be used in the area where the testing is needed to get a response quickly on the results.
Maybe it was Nielsen who dumped the 70 million. Then dumped 40 million. He reported the amount that put him under the reporting number. So 40 million was reported. Just a guess. Is it legal, don't know. Is that what happened? Is it possible?; just a guess.
If you need the covid test tell them you don't want a test from a form 15 company.
SEARCH MARKETWATCH
Home
PRESS RELEASEArrayit Corporation Reports Clinical Instrumentation Sale to the United States Food and Drug Administration
By
Published: July 16, 2018 5:30 a.m. ET
July 16, 2018 - Sunnyvale, CA - Arrayit Corporation (OTC: ARYC), a life sciences and personalized medicine company, announces the sale of clinical instrumentation to the United States Food and Drug Administration (FDA). Arrayit uses the same clinical instrumentation in its Clinical Laboratory Improvement Amendments (CLIA) laboratory licensed by the Centers for Medicare and Medicaid Services (CMS) and the State of California Department of Public Health (CDPH). The instrumentation reads and reports test results for the company's allergy and dietary wellness tests and pipeline tests for ovarian cancer and Parkinson's Disease (PD).
Arrayit recently scored 100% on immunoglobulin E (IgE) proficiency testing with the College of American Pathologists, announced a nationwide sales network of 1,700 professional sales representatives to sell and distribute the company's finger stick tests, and completed pilot testing with one the nation's largest chains of retail stores. Arrayit microarray tests conveniently use a few drops of blood collected on a blood card to assist doctors in identifying and treating allergy, asthma, dietary intolerance and pipeline indications for ovarian cancer and PD. The company recently met with top officials at the FDA to discuss FDA approval of a major product line. The FDA ensures the safety of food, drugs and medical devices by regulating consumer products exceeding $1,000,000,000,000 ($1 trillion) in annual revenues.
Arrayit CEO Rene Schena states, "The sale of clinical instrumentation to the FDA advances our personalized medicine initiatives by strengthening ties with the nation's preeminent regulatory agency. Our transformative healthcare products and services benefit from transparency in the hands of top FDA scientists."
About Arrayit
Arrayit Corporation, headquartered in Sunnyvale, California, leads and empowers the research, biotechnology, pharmaceutical, clinical and healthcare sectors through the discovery, development and manufacture of proprietary life science and personalized medicine products and services to advance biomedical research and improve wellness and human health. Please visit www.arrayit.com for more information.
Safe Harbor Statement
We have identified forward-looking statements by using words such as "expect", "believe", and "should". Although we believe our expectations are reasonable, our operations involve a number of risks and uncertainties that are beyond our control, and these statements may turn out not to be true. Risk factors associated with our business, including some of the facts set forth herein, are detailed in the Company's public filings.
CONTACT
Public Relations
Arrayit Corporation
Tel: 408-744-1331
Email: arrayit@arrayit.com
Web: www.arrayit.com
CONTACT Public Relations Arrayit Corporation Tel: 408-744-1331 Email: arrayit@arrayit.com Web: www.arrayit.com
Copyright (C) 2018 GlobeNewswire, Inc. All rights reserved.
Years back the FDA bought testing equipment from ARRAYIT.
Did anyone inform CNBC about Arrayit's coronavirus test?
Maybe the coronavirus test should be given alongside the al·ler·gy test. Double the revenue.
It would be nice to see a coronavirus portal login. Maybe, it will be tied to the allergery portal.
It would be nice if they give the operating capacity with the all the testing being performed after the release of financials or at the appropriate time.
One thing good about arrayit is years back they kept expanding their capacity. Whether it's beneficial use can be turned into coronavirus testing is unknown to me. The coronavirus testing could be prioritized over allergery testing. If arrayit is doing the coronavirus test.
Is their a way to go on a government website to see the submission of the test?